Synchronyx Named a Quarterfinalist in the 2026 Digital Health & AI Awards
Tappt® recognized in the Rising Star track, Therapeutics, Pharmacy & Medication Innovation category
Synchronyx has been named a Quarterfinalist in the 2026 Digital Health & AI Awards in the Rising Star track, Therapeutics, Pharmacy & Medication Innovation category.
The company was recognized for the Tappt® Medication Intelligence Platform, which addresses a persistent gap in medication care: limited visibility into what happens after a medication is prescribed and dispensed.
Tappt combines patient-confirmed medication events with reported barriers and relevant clinical context. This helps pharmacists and care teams identify missed doses, symptoms, side effects, access challenges, packaging confusion, and other risks while there is still an opportunity to respond.
“Medication records can tell us what was prescribed and dispensed, but they rarely show what the patient experiences once treatment begins,” said Tamar Sapir, PhD, Founder and CEO of Synchronyx. “Tappt was designed to make medication use and treatment barriers visible while care teams can still act. This recognition reflects the work of our team and the healthcare organizations, pharmacists, researchers, and industry partners working with us to improve the medication journey.”
The Digital Health & AI Awards recognize companies and technologies helping shape the future of healthcare. Participating companies are evaluated by leaders representing healthcare, investment, technology, clinical care, and other areas of the health ecosystem.
“Each year, the Awards give us a front-row seat to the technologies, companies and leaders working to move healthcare forward,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. “Congratulations to our 2026 Quarterfinalists. We are excited to recognize their work and follow their progress as we move toward the Grand Finale at HLTH.”
Finalists will be announced on October 12, 2026. The competition will culminate at the Digital Health & AI Awards Grand Finale on November 16 at HLTH in Las Vegas.
Meet Synchronyx at HLTH
The Synchronyx team will be at HLTH from November 16 through November 18 in the Digital Health Hub Foundation Awards Pavilion, booth 1151-40.
Visit us to learn how Tappt helps healthcare organizations make medication journeys more visible, measurable, and actionable.
Schedule a meeting with the Synchronyx team at HLTH.
About Synchronyx
Synchronyx develops technology that helps healthcare organizations understand and respond to what happens between prescription and outcome.
Its Tappt® Medication Intelligence Platform combines battery-free NFC smart labels, patient-confirmed medication events, patient-reported barriers, and care-team workflows. The platform gives health systems, pharmacies, research programs, and life sciences organizations more timely insight into medication use outside the clinic.
Learn more at synchronyx.com.
